FDA clears Mirador’s pressure sensing products
This article was originally published in Clinica
The US FDA has granted 510(k) clearance for Mirador Biomedical’s Compass Vascular Access and Compass Lumbar Puncture, its two lead products. The former is a pressure sensor for use during the insertion of central venous catheters, while the latter is used to measure pressure during lumbar puncture. The Compass Vascular Access device can help physicians distinguish between arteries and veins by measuring blood pressure, which is shown on a digital display. This reduces the risk of puncturing an artery, which can lead to death from stroke, airway compression or haemorrhage. Seattle, Washington-based Mirador claims that its Compass Lumbar Puncture product is more accurate than manometry, the standard method of measuring pressure during the procedure, which quantifies muscle pressure.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.